| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |